1
|
Streuli I, Casini A, Benard J, Poncet A, Fontana P, Vulliemoz N, Hugon-Rodin J. P–622 Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive techniques. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Does the evolution of prothrombotic biomarkers over time differ between antagonist and long agonist stimulation protocols for assisted reproductive techniques (ART) ?
Summary answer
The hypercoagulable state was higher and persistent in the agonist and antagonist with hCG triggering groups compared to the antagonist with GnRH agonist triggering group.
What is known already
Controlled ovarian stimulation (COS) for ART is associated with supra-physiological serum estradiol levels, a hypercoagulable state and an increased risk of venous thrombosis. Most thromboembolic events associated with COS occur in the context of ovarian hyperstimulation syndrome (OHSS). The use of hCG for final follicular maturation increases the risk of OHSS. In antagonist protocols, GnRH agonist triggering is known to prevent or reduce OHSS and is therefore widely used in women at risk. The impact of the different IVF protocols on pro-thrombotic biomarkers is unknown.
Study design, size, duration
In this prospective observational cohort study, infertile women undergoing COS for ART in 2017–2019 at the University Hospitals of Geneva and Lausanne (Switzerland) were included. We evaluated changes in key coagulation parameters (D-dimers, factor VIII, fibrinogen activity, protein S and protein C) and thrombin generation, our primary outcome, (using 5 pM of tissue factor) by calibrated automated thrombinography before stimulation (T1), on the day of ovulation triggering (T2) and seven days after triggering (T3).
Participants/materials, setting, methods
COS was started without hormonal pre-treatment. Protocols were prescribed according to the standards used in each centre taking into account the risk of OHSS (agonist protocol with hCG trigger in women without OHSS risk (Group 1); antagonist protocol in women at risk of OHSS with hCG trigger (Group 2;) or GnRH agonist trigger (Group 3;); variation of endogenous thrombin potential (ETP) was measured and compared among groups using mixed effects linear regression model.
Main results and the role of chance
A total of 64 women were included: 24 were in group 1, 16 in group 2, and 24 in group 3. The mean age (SD) was 37.8 (2.8), 35.9(5.2) and 34(4.6) years in groups 1, 2 and 3 respectively. As expected, women in group 1 had a statistically lower level of anti-müllerian hormone (p = <0.001), a lower antral follicular count (p = <0.001) and lower number of MII oocytes and embryos obtained (p = <0.001). Mean serum estradiol levels were 1836 (1160), 1628 (815) and 3754 (2165) ng/L at T2, and 945 (471), 1061 (495) and 413 (729) ng/L at T3, in group 1 to 3, respectively. In multivariable regression analysis, the levels in group 3 were statistically higher at T2 and lower at T3 (overall time*group interaction: p < 0.001). The mean ETP was similar between all groups at T1, and increased in all groups at T2 (1442, 1426 and 1486 nM/min in groups 1, 2 and 3, respectively) (p = 0.013). Overall, ETP evolution over time was statistically different between groups, with the lowest increase of ETP between T1 and T3 in group 3. Protein C and protein S levels were stable, while D-dimers, fibrinogen and factor VIII increased at T2 and T3 in all groups.
Limitations, reasons for caution
Stimulation protocols were prescribed according to the clinical profile and OHSS risks; groups therefore differ substantially in regards to age and ovarian reserve. Thromboembolic events are rare events after COS, we therefore evaluated biological markers of hypercoagulability and not clinical events.
Wider implications of the findings: Women with GnRH agonist triggering protocol did not increase mean ETP in the week after ovulation, while women with hCG triggering did. This different prothrombotic profile was independent of the variation of the other coagulation parameters investigated. This effect of ovulation triggering should be confirmed by further studies.
Trial registration number
NCT04188444
Collapse
Affiliation(s)
- I Streuli
- University Hospitals of geneva and the Faculty of medicine of the geneva University, DFEA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| | - A Casini
- University Hospitals of geneva and the Faculty of medicine of the geneva University, Département de médecine - service d’angiologie et d’hémostase, Geneva, Switzerland
| | - J Benard
- University Hospitals of geneva and the Faculty of medicine of the geneva University, DFEA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| | - A Poncet
- University Hospitals of geneva and the Faculty of medicine of the geneva University, Centre de recherche clinique - service d’épidémiologie clinique, Geneva, Switzerland
| | - P Fontana
- University Hospitals of geneva and the Faculty of medicine of the geneva University, Département de médecine - service d’angiologie et d’hémostase, Geneva, Switzerland
| | - N Vulliemoz
- University Hospitals of Lausanne and the Faculty of medicine of the Lausanne University, DFMA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| | - J Hugon-Rodin
- University Hospitals of geneva and the Faculty of medicine of the geneva University, DFEA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| |
Collapse
|
2
|
Streuli I, Casini A, Benard J, Poncet A, Fontana P, Vulliemoz N, Hugon-Rodin J. P-622 Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive techniques. Hum Reprod 2021. [DOI: 10.1093/humrep/deab125.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Does the evolution of prothrombotic biomarkers over time differ between antagonist and long agonist stimulation protocols for assisted reproductive techniques (ART) ?
Summary answer
The hypercoagulable state was higher and persistent in the agonist and antagonist with hCG triggering groups compared to the antagonist with GnRH agonist triggering group.
What is known already
Controlled ovarian stimulation (COS) for ART is associated with supra-physiological serum estradiol levels, a hypercoagulable state and an increased risk of venous thrombosis. Most thromboembolic events associated with COS occur in the context of ovarian hyperstimulation syndrome (OHSS). The use of hCG for final follicular maturation increases the risk of OHSS. In antagonist protocols, GnRH agonist triggering is known to prevent or reduce OHSS and is therefore widely used in women at risk. The impact of the different IVF protocols on pro-thrombotic biomarkers is unknown.
Study design, size, duration
In this prospective observational cohort study, infertile women undergoing COS for ART in 2017-2019 at the University Hospitals of Geneva and Lausanne (Switzerland) were included. We evaluated changes in key coagulation parameters (D-dimers, factor VIII, fibrinogen activity, protein S and protein C) and thrombin generation, our primary outcome, (using 5 pM of tissue factor) by calibrated automated thrombinography before stimulation (T1), on the day of ovulation triggering (T2) and seven days after triggering (T3).
Participants/materials, setting, methods
COS was started without hormonal pre-treatment. Protocols were prescribed according to the standards used in each centre taking into account the risk of OHSS (agonist protocol with hCG trigger in women without OHSS risk (Group 1); antagonist protocol in women at risk of OHSS with hCG trigger (Group 2;) or GnRH agonist trigger (Group 3;); variation of endogenous thrombin potential (ETP) was measured and compared among groups using mixed effects linear regression model.
Main results and the role of chance
A total of 64 women were included: 24 were in group 1, 16 in group 2, and 24 in group 3. The mean age (SD) was 37.8 (2.8), 35.9(5.2) and 34(4.6) years in groups 1, 2 and 3 respectively. As expected, women in group 1 had a statistically lower level of anti-müllerian hormone (p = < 0.001), a lower antral follicular count (p = < 0.001) and lower number of MII oocytes and embryos obtained (p = < 0.001). Mean serum estradiol levels were 1836 (1160), 1628 (815) and 3754 (2165) ng/L at T2, and 945 (471), 1061 (495) and 413 (729) ng/L at T3, in group 1 to 3, respectively. In multivariable regression analysis, the levels in group 3 were statistically higher at T2 and lower at T3 (overall time*group interaction: p < 0.001).
The mean ETP was similar between all groups at T1, and increased in all groups at T2 (1442, 1426 and 1486 nM/min in groups 1, 2 and 3, respectively) (p = 0.013). Overall, ETP evolution over time was statistically different between groups, with the lowest increase of ETP between T1 and T3 in group 3. Protein C and protein S levels were stable, while D-dimers, fibrinogen and factor VIII increased at T2 and T3 in all groups.
Limitations, reasons for caution
Stimulation protocols were prescribed according to the clinical profile and OHSS risks; groups therefore differ substantially in regards to age and ovarian reserve. Thromboembolic events are rare events after COS, we therefore evaluated biological markers of hypercoagulability and not clinical events.
Wider implications of the findings
Women with GnRH agonist triggering protocol did not increase mean ETP in the week after ovulation, while women with hCG triggering did. This different prothrombotic profile was independent of the variation of the other coagulation parameters investigated. This effect of ovulation triggering should be confirmed by further studies.
Trial registration number
NCT04188444
Collapse
Affiliation(s)
- I Streuli
- University Hospitals of geneva and the Faculty of medicine of the geneva University, DFEA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| | - A Casini
- University Hospitals of geneva and the Faculty of medicine of the geneva University, Département de médecine - service d’angiologie et d’hémostase, Geneva, Switzerland
| | - J Benard
- University Hospitals of geneva and the Faculty of medicine of the geneva University, DFEA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| | - A Poncet
- University Hospitals of geneva and the Faculty of medicine of the geneva University, Centre de recherche clinique - service d’épidémiologie clinique, Geneva, Switzerland
| | - P Fontana
- University Hospitals of geneva and the Faculty of medicine of the geneva University, Département de médecine - service d’angiologie et d’hémostase, Geneva, Switzerland
| | - N Vulliemoz
- University Hospitals of Lausanne and the Faculty of medicine of the Lausanne University, DFMA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| | - J Hugon-Rodin
- University Hospitals of geneva and the Faculty of medicine of the geneva University, DFEA-Ob/Gyn-reproductive medicine, Geneva, Switzerland
| |
Collapse
|
3
|
Navarria-Forney I, Bénard J, Mazloum A, Aerts L, Pluchino N, Streuli I. A web-based survey of reproductive awareness and choices in women with endometriosis. Eur J Obstet Gynecol Reprod Biol 2020; 251:106-113. [PMID: 32497984 DOI: 10.1016/j.ejogrb.2020.05.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2020] [Revised: 05/04/2020] [Accepted: 05/07/2020] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Our aim was to study fertility issues, attitudes towards reproductive techniques and fertility preservation options in women of reproductive age with endometriosis. STUDY DESIGN In 2018 we conducted a web-based survey on fertility issues in women aged 18-40 years with endometriosis. Participants were recruited via advertisements on social media and local endometriosis support groups. Participants completed a self-developed online questionnaire evaluating the following dimensions: sociodemographic, medical data, parental project, knowledge and attitudes toward endometriosis and fertility, means used to access information, and reproductive choices. RESULTS The majority of women (96 %) worried about the impact of endometriosis on their fertility. Approximately half of them (52 %) reported having received sufficient information concerning the effect of endometriosis on fertility from their doctor, whereas 31 % had discussed fertility issues with their doctor but desired further information. In contrast, only a minority (27 %) of women considered themselves well-informed on fertility preservation options. Information given by specialists on endometriosis and reproduction was considered most useful. Information mediated through patient support groups was also highly rated, whereas information given by the general gynecologist was less highly rated. The majority of women would consider assisted reproductive techniques (74 %) or adoption (70 %) in case of infertility. Interestingly, 72 % of women would undergo oocyte vitrification for fertility preservation, whereas only 37 % would resort to oocyte donation. CONCLUSION This is the first survey to address the topic of fertility issues from the patient's perspective in women with endometriosis. The vast majority of women attach great importance to a discussion about fertility possibilities and only a minority of women consider themselves well-informed. Our results highlight the importance of addressing the issue of fertility in women with endometriosis. Special attention should be given to information and counselling about fertility preservation options since most women consider their knowledge on the topic insufficient. Knowledge and attitudes to counsel endometriosis patients on fertility issues and fertility preservation options should be included in the training curricula of gynecologists. Adequate information on reproductive aging, risk factors for infertility, and reproductive choices, including oocyte vitrification, should be incorporated into follow-up visits for endometriosis patients.
Collapse
Affiliation(s)
- I Navarria-Forney
- Reproductive Medicine Unit, Division of Gynaecology, Geneva University Hospitals and the Faculty of Medicine of University of Geneva, Switzerland
| | - J Bénard
- Reproductive Medicine Unit, Division of Gynaecology, Geneva University Hospitals and the Faculty of Medicine of University of Geneva, Switzerland
| | - A Mazloum
- Division for Liaison Psychiatry and Crisis Intervention, Geneva University Hospitals and the Faculty of Medicine of University of Geneva, Switzerland
| | - L Aerts
- Department of Paediatrics, Gynaecology and Obstetrics, Division of Gynaecology, Geneva University Hospitals and the Faculty of Medicine of University of Geneva, Switzerland
| | - N Pluchino
- Department of Paediatrics, Gynaecology and Obstetrics, Division of Gynaecology, Geneva University Hospitals and the Faculty of Medicine of University of Geneva, Switzerland
| | - I Streuli
- Reproductive Medicine Unit, Division of Gynaecology, Geneva University Hospitals and the Faculty of Medicine of University of Geneva, Switzerland.
| |
Collapse
|
4
|
Jordans IPM, de Leeuw RA, Stegwee SI, Amso NN, Barri‐Soldevila PN, van den Bosch T, Bourne T, Brölmann HAM, Donnez O, Dueholm M, Hehenkamp WJK, Jastrow N, Jurkovic D, Mashiach R, Naji O, Streuli I, Timmerman D, van der Voet LF, Huirne JAF. Sonographic examination of uterine niche in non-pregnant women: a modified Delphi procedure. Ultrasound Obstet Gynecol 2019; 53:107-115. [PMID: 29536581 PMCID: PMC6590297 DOI: 10.1002/uog.19049] [Citation(s) in RCA: 103] [Impact Index Per Article: 20.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2017] [Revised: 02/07/2018] [Accepted: 02/16/2018] [Indexed: 05/19/2023]
Abstract
OBJECTIVE To generate guidance for detailed uterine niche evaluation by ultrasonography in the non-pregnant woman, using a modified Delphi procedure amongst European experts. METHODS Twenty gynecological experts were approached through their membership of the European Niche Taskforce. All experts were physicians with extensive experience in niche evaluation in clinical practice and/or authors of niche publications. By means of a modified Delphi procedure, relevant items for niche measurement were determined based on the results of a literature search and recommendations of a focus group of six Dutch experts. It was predetermined that at least three Delphi rounds would be performed (two online questionnaires completed by the expert panel and one group meeting). For it to be declared that consensus had been reached, a consensus rate for each item of at least 70% was predefined. RESULTS Fifteen experts participated in the Delphi procedure. Consensus was reached for all 42 items on niche evaluation, including definitions, relevance, method of measurement and tips for visualization of the niche. A niche was defined as an indentation at the site of a Cesarean section with a depth of at least 2 mm. Basic measurements, including niche length and depth, residual and adjacent myometrial thickness in the sagittal plane, and niche width in the transverse plane, were considered to be essential. If present, branches should be reported and additional measurements should be made. The use of gel or saline contrast sonography was preferred over standard transvaginal sonography but was not considered mandatory if intrauterine fluid was present. Variation in pressure generated by the transvaginal probe can facilitate imaging, and Doppler imaging can be used to differentiate between a niche and other uterine abnormalities, but neither was considered mandatory. CONCLUSION Consensus between niche experts was achieved regarding ultrasonographic niche evaluation. © 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
Collapse
Affiliation(s)
- I. P. M. Jordans
- Department of Obstetrics and Gynecology, Amsterdam Cardiovascular SciencesVU Medical CentreAmsterdamThe Netherlands
| | - R. A. de Leeuw
- Department of Obstetrics and Gynecology, Amsterdam Cardiovascular SciencesVU Medical CentreAmsterdamThe Netherlands
| | - S. I. Stegwee
- Department of Obstetrics and Gynecology, Amsterdam Cardiovascular SciencesVU Medical CentreAmsterdamThe Netherlands
| | - N. N. Amso
- Department of Obstetrics and GynecologyCardiff UniversityCardiffUK
| | | | | | - T. Bourne
- Department of Obstetrics and GynecologyImperial College LondonLondonUK
| | - H. A. M. Brölmann
- Department of Obstetrics and Gynecology, Amsterdam Cardiovascular SciencesVU Medical CentreAmsterdamThe Netherlands
| | - O. Donnez
- Institut du sien et de Chirurgie Gynécologique d'AvignonPolyclinique Urbain V (Elsan Group)AvignonFrance
- Institut de Recherche Experimentale et CliniqueUniversité Catholique de LouvainBruxellesBelgium
| | - M. Dueholm
- Department of Obstetrics and GynecologyAarhus University HospitalAarhusDenmark
| | - W. J. K. Hehenkamp
- Department of Obstetrics and Gynecology, Amsterdam Cardiovascular SciencesVU Medical CentreAmsterdamThe Netherlands
| | - N. Jastrow
- Department of Obstetrics and GynecologyHôpitaux Universitaires de Genève, GenèveSwitzerland
| | - D. Jurkovic
- Department of Obstetrics and GynaecologyUniversity College HospitalLondonUK
| | - R. Mashiach
- Department of Obstetrics and GynecologySheba Medical CenterRamat GanIsrael
| | - O. Naji
- Department of Obstetrics and GynecologyImperial College LondonLondonUK
| | - I. Streuli
- Department of Obstetrics and GynecologyHôpitaux Universitaires de Genève, GenèveSwitzerland
| | - D. Timmerman
- Department of Obstetrics and GynecologyKU LeuvenLeuvenBelgium
| | - L. F. van der Voet
- Department of Obstetrics and GynecologyDeventer HospitalDeventerThe Netherlands
| | - J. A. F. Huirne
- Department of Obstetrics and Gynecology, Amsterdam Cardiovascular SciencesVU Medical CentreAmsterdamThe Netherlands
| |
Collapse
|
5
|
Abstract
Endometriosis is a hormone-dependent inflammatory disease that is usually characterized by infertility and pain symptoms. This disease mainly occurs during the reproductive years and is rarely diagnosed after menopause. We discuss the physiopathology of this condition after menopause as well as treatment options and the risk of malignant transformation. Occurrence or progression of postmenopausal endometriosis lesions could be related to extra-ovarian production of estrogen by endometriosis lesions and adipose tissue, which becomes the major estrogen-producing tissue after menopause. Postmenopausal women with symptomatic endometriosis should be managed surgically because of the risk of malignancy; medical treatments can be used in cases of pain recurrence after surgery. Aromatase inhibitors act by decreasing extra-ovarian estrogen production and by blocking the feed-forward stimulation loop between inflammation and aromatase within endometriosis lesions. The evidence is currently insufficient to support a conclusion about the optimal hormone replacement therapy for women with endometriosis. The question of malignant transformation of endometriosis in response to hormone replacement therapy in women with a history of endometriosis remains unanswered and needs a long-term follow-up study to evaluate the risk of an adverse outcome. Further studies should be performed to determine the optimal management of menopausal women with endometriosis.
Collapse
Affiliation(s)
- I Streuli
- a Department of Gynecology and Obstetrics , University Hospitals of Geneva , Geneva , Switzerland
| | - H Gaitzsch
- a Department of Gynecology and Obstetrics , University Hospitals of Geneva , Geneva , Switzerland
| | - J-M Wenger
- a Department of Gynecology and Obstetrics , University Hospitals of Geneva , Geneva , Switzerland
| | - P Petignat
- a Department of Gynecology and Obstetrics , University Hospitals of Geneva , Geneva , Switzerland
| |
Collapse
|
6
|
Cantero Pérez P, Klingemann J, Yaron M, Irion NF, Streuli I. [Contraception during the perimenopause: indications, security, and non contraceptive benefits]. Rev Med Suisse 2015; 11:1986-1992. [PMID: 26672176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Although patients' fertility is diminished in the period of perimenopause, they still need efficient contraception. Thorough knowledge of the physiological changes occuring during this period of transition is essential in order to provide optimal care. Until the age of 50, no contraceptive method is specifically considered unsuitable due to age alone. The choice of contraceptive needs to be adapted to the patient, assessing the individual risk factors and favouring the potential non-contraceptive advantages of the method selected. Long-term contraceptive methods (e.g., the copper intrauterine device (IUD), the Mirena IUD or a subcutaneous implant) offer an excellent solution on both levels.
Collapse
|
7
|
Dubuisson J, Ramyead L, Streuli I. The role of preventive uterine artery occlusion during laparoscopic myomectomy: a review of the literature. Arch Gynecol Obstet 2014; 291:737-43. [DOI: 10.1007/s00404-014-3546-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2014] [Accepted: 11/05/2014] [Indexed: 10/24/2022]
|
8
|
Santulli P, Thubert T, Marcellin L, Menard S, Streuli I, Borghese B, de Ziegler D, Chapron C. Measurement of hs-CRP Is Irrelevant for Diagnosing and Staging of Endometriosis: A Prospective Study of 834 Patients. J Minim Invasive Gynecol 2013. [DOI: 10.1016/j.jmig.2013.08.462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Andrey Urias A, Martinez De Tejada B, Monnier S, Streuli I, Irion O. [What's new in gynecology and obstetrics in 2012?]. Rev Med Suisse 2013; 9:44-47. [PMID: 23367703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Intraoperative radiotherapy (IORT) has been shown to be as effective as traditional radiotherapy in the management of early stage breast cancer. IORT is performed in a single session and consists in a single irradiation in the tumorectomy cavity. Medically assisted procreation does not seem to favor neither gynecological nor non-gynecological cancers. Nevertheless medically assisted procreation technique ICSI (intracytoplasmic sperm injection) is associated with an increased risk of birth defect. This is not the case of IVF (in vitro fertilization). The causality of the treatment or of the infertility itself is unclear. During pregnancy, nicotine-replacement patches at usual dosage do not seem to increase abstinence smoking rates. A selective, and not a systematic thyroid screening strategy, is now recommended during first trimester of pregnancy.
Collapse
Affiliation(s)
- A Andrey Urias
- Service de gynécologie, Département de gynécologie et d'obstétrique, HUG et Faculté de médecine, Genève.
| | | | | | | | | |
Collapse
|
10
|
Santulli P, Borghese B, Chouzenoux S, Batteux F, Streuli I, de Ziegler D, Chapron C. Interleukin-19 and Interleukin-22 Levels Are Decreased in Sera of Women with Ovarian Endometrioma. J Minim Invasive Gynecol 2012. [DOI: 10.1016/j.jmig.2012.08.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
11
|
Chapron C, Santulli P, Sibiude J, Borghese B, Streuli I, de Ziegler D. Past Surgical History for Endometriosis Is a Marker for Presence and Severity of Deeply Infiltrating Endometriosis. J Minim Invasive Gynecol 2012. [DOI: 10.1016/j.jmig.2012.08.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
12
|
Borghese B, Chartier M, Souza C, Santulli P, Streuli I, Lafay Pillet MC, de Ziegler D, Chapron C. ABO and Rhesus Blood Groups and Risk of Endometriosis. J Minim Invasive Gynecol 2012. [DOI: 10.1016/j.jmig.2012.08.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Streuli I, Bouba S, Gayet V, Chapron C, Viot G, de Ziegler D. FMR1 gene alleles in infertile women with primary ovarian insufficiency, diminished ovarian reserve and poor response to ovarian stimulation. Fertil Steril 2012. [DOI: 10.1016/j.fertnstert.2012.07.485] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
14
|
Streuli I, de Ziegler D, Gayet V, Santulli P, Bijaoui G, de Mouzon J, Chapron C. In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod 2012; 27:3294-303. [DOI: 10.1093/humrep/des274] [Citation(s) in RCA: 116] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
Nesbitt-Hawes E, Campbell N, Won H, Maley P, Henry A, Abbott J, Potdar N, Mason-Birks S, Elson CJ, Gelbaya TA, Nardo LG, Stavroulis A, Nnoaham K, Hummelshoj L, Zondervan K, Saridogan E, GSWH Consortium WERF, Chamie LP, Soares ACP, Kimati CT, Gomes C, Fettback P, Riboldi M, Serafini P, Lalitkumar S, Menezes J, Evdokia D, Gemzell-Danielsson K, Lalitkumar PGL, Bailey J, Newman TA, Johnston A, Zisimopoulou K, White M, Sadek K, Shreeve N, Macklon N, Cheong Y, Al-Akoum M, Akoum A, Giles J, Garrido N, Vidal C, Mondion M, Gallo C, Ramirez J, Pellicer A, Remohi J, Ghosh S, Chattopadhyay R, Jana S, Goswami SK, Bose G, Chakravarty M, Chowdhuri K, Chakravarty BN, Kendirci Ceviren A, Ozcelik Tanriverdi N, Urfan A, Donmez L, Isikoglu M, Romano A, Schreinemacher MH, Backes WH, Slenter JM, Xanthoulea SA, Delvoux B, van Winden L, Beets-Tan RG, Evers JLH, Dunselman GAJ, Jana SK, Chaudhury K, Chattopadhyay R, Chakravarty BN, Maruyama T, Yamasaki A, Miyazaki K, Arase T, Uchida H, Yoshimura Y, Kaser D, Ginsburg E, Missmer S, Correia K, Racowsky C, Streuli I, Chouzenoux S, de Ziegler D, Chereau C, Weill B, Chapron C, Batteux F, Arianmanesh M, Fowler PA, Al-Gubory KH, Urata Y, Osuga Y, Izumi G, Nagai M, Takamura M, Yamamoto N, Saito A, Hasegawa A, Takemura Y, Harada M, Hirata T, Hirota Y, Yoshino O, Koga K, Taketani Y, Mohebbi A, Janan A, Nasri S, Lakpour MR, Ramazanali F, Moini A, Aflatoonian R, Germeyer A, Novak O, Renke T, Jung M, Jackus J, Toth B, Strowitzki T, Bhattacharya J, Mitra A, Kundu S, Pal M, Kundu A, Gumusel A, Basar M, Yaprak E, Aslan E, Arda O, Ilvan S, Kayisli U, Guzel E, Haouzi D, Monzo C, Lehmann S, Hirtz C, Tiers L, Hamamah S, Choi D, Choi J, Jo M, Lee E, Shen X, Wang BIN, Li X, Tamura I, Maekawa R, Asada H, Tamura H, Sugino N, Tamura H, Tamura I, Maekawa R, Asada H, Sugino N, Liu H, Jiang Y, Chen J, Zhu L, Shen X, Wang B, Yan G, Sun H, Coughlan C, Sinagra M, Ledger W, Li TC, Laird SM, Dafopoulos K, Vrekoussis T, Chalvatzas N, Messini CI, Kalantaridou S, Georgoulias P, Messinis IE, Makrigiannakis A, Xue Q, Xu Y, Zuo WL, Zhang L, Shang J, Zhu SN, Bulun SE, Tomassetti C, Geysenbergh B, Meuleman C, Fieuws S, D'Hooghe T, Suginami K, Sato Y, Horie A, Matsumoto H, Fujiwara H, Konishi I, Jung Y, Cho S, Choi Y, Lee B, Seo S, Urman B, Yakin K, Oktem O, Alper E, Taskiran C, Aksoy S, Takeuchi K, Kurematsu T, Yu-ki Y, Fukumoto Y, Homan Y, Sata Y, Kuroki Y, Takeuchi M, Awata S, Muneyyirci-Delale O, Charles C, Anopa J, Osei-Tutu N, Dalloul M, Weedon J, Muney A, Stratton P, Yilmaz B, Kilic S, Aksakal O, Kelekci S, Aksoy Y, Lordlar N, Sut N, Gungor T, Chan J, Tan CW, Lee YH, Tan HH, Choolani M, Griffith L, Oldeweme J, Barcena de Arellano ML, Reichelt U, Schneider A, Mechsner S, Barcena de Arellano ML, Munch S, Vercellino GF, Chiantera V, Schneider A, Mechsner S, Santoro L, D'Onofrio F, Campo S, Ferraro PM, Tondi P, Gasbarrini A, Santoliquido A, Jung MH, Kim HY, Barcena de Arellano ML, Arnold J, Vercellino GF, Chiantera V, Schneider A, Mechsner S, Arnold J, Barcena de Arellano ML, Buttner A, Vercellino GF, Chiantera V, Schneider A, Mechsner S, Karaer A, Celik O, Bay Karabulut A, Celik E, Kiran TR, Simsek OY, Yilmaz E, Turkcuoglu I, Tanrikut E, Alieva K, Kulakova E, Ipatova M, Smolnikova V, Kalinina E. ENDOMETRIOSIS, ENDOMETRIUM, IMPLANTATION AND FALLOPIAN TUBE. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.78] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
16
|
Moulin J, Marszalek A, Gayet V, Blanchet V, Streuli I, Lafay M, Pont JC, Chapron C, De Ziegler D, Moolenaar LM, Verhoeve HR, van der Veen F, Hompes P, Mol BWJ, Savasi V, Oneta M, Elli M, Parilla B, Loareti A, Cetin I, Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S, Simsek Y, Celik O, Yilmaz E, Karaer A, Koc O, Aydin NE, Rodriguez S, Agudo D, Pacheco A, Garcia-Cerrudo E, Schneider J, Garcia-Velasco JA. SELECTED ORAL COMMUNICATION SESSION, SESSION 35: ENDOMETRIOSIS, Tuesday 5 July 2011 10:00 - 11:30. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.35] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
17
|
Watanabe A, Jinno M, Hirohama J, Hatakeyama N, Hiura R, Sterrenburg M, Blockeel C, Eijkemans MJ, Broer SL, Macklon NS, Broekmans FJ, Devroey P, Fauser BCJM, Al-Karaki R, Irzouqi R, Khalifa F, Taher M, Sarraf M, Cedrin - Durnerin I, Guivarch A, Hugues JN, Bstandig B, Parneix I, Vasseur C, Dubourdieu S, Colombel A, Marszalek A, Gayet V, Blanchet V, Streuli I, Chalas Boissonnas C, Chapron C, de Ziegler D, Banga FR, Lambalk CB, Huirne JA, van Wely M, van der Veen F. SELECTED ORAL COMMUNICATION SESSION, SESSION 33: AGONISTS AND ANTAGONISTS, Tuesday 5 July 2011 10:00 - 11:30. Hum Reprod 2011. [DOI: 10.1093/humrep/26.s1.33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|